Education
About Us
Working with TipRanks
Follow Us
Comprehensive Healthcare Systems Inc (TSE:CHS)
:CHS
Top Page
Comprehensive Healthcare Systems Inc
(CHS)
Select Model
Select Model
Rating:44Neutral
Price Target:―
The overall stock score reflects significant financial challenges, including ongoing losses, high leverage, and negative cash flows. While technical indicators suggest short-term momentum, the valuation remains unattractive due to a negative P/E ratio and lack of dividends. Strategic financial restructuring is critical for long-term viability.
Comprehensive Healthcare Systems Inc (CHS) vs. iShares MSCI Canada ETF (EWC)
Market Cap
C$9.87M
Dividend YieldN/A
Average Volume (3M)4.03K
Price to Earnings (P/E)―
Beta (1Y)0.65
Revenue Growth12.44%
EPS Growth74.38%
CountryCA
EmployeesN/A
SectorHealthcare
Sector Strength45
IndustryMedical - Healthcare Information Services
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding17,948,122
10 Day Avg. Volume3,650
30 Day Avg. Volume4,032
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)-0.13
Price to Sales (P/S)0.33
P/FCF Ratio34.16
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Comprehensive Healthcare Systems Inc Business Overview & Revenue Model
Company DescriptionComprehensive Healthcare Systems Inc (CHS) is a company that operates within the healthcare technology sector, focusing on providing innovative solutions and services to improve healthcare delivery and management. The company offers a range of products and services, including healthcare management software, electronic health records (EHR) solutions, and consulting services aimed at optimizing healthcare processes and improving patient outcomes.
How the Company Makes MoneyCHS generates revenue primarily through the sale of its healthcare management software and electronic health records solutions. These products are offered to healthcare providers, hospitals, and clinics on a subscription or licensing basis, providing a steady stream of income. Additionally, the company earns from consulting services, where it assists healthcare organizations in implementing and optimizing their systems. Significant partnerships with healthcare providers and technology firms further enhance their market reach and contribute to revenue growth.
Comprehensive Healthcare Systems Inc Financial Statement Overview
Summary
Comprehensive Healthcare Systems Inc is facing significant financial challenges. Despite some improvement in gross profitability, persistent net losses, a weak balance sheet with high leverage, and negative cash flows highlight financial instability.Income Statement
The income statement shows a declining trend in revenue with a negative net profit margin of -3.4% in the TTM period. Gross profit margin improved to 43.3% from the previous year, indicating effective cost control. However, consistent net losses and negative EBITDA highlight ongoing operational challenges.35
Negative
Balance Sheet
The balance sheet reveals a negative stockholders' equity, indicating insolvency risks. A high debt-to-equity ratio is concerning, suggesting financial instability. Equity ratio is negative due to liabilities exceeding assets. These factors point to significant financial leverage and risk.20
Very Negative
Cash Flow
Cash flow analysis indicates negative free cash flow, hampering operational flexibility. The operating cash flow to net income ratio is positive, showing some cash generation ability, but overall cash flow trends are weak, with reliance on external financing.25
Negative
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 4.02M | 3.77M | 3.84M | 4.30M | 4.50M | 4.74M |
| Gross Profit | 2.40M | 2.06M | 1.15M | 1.40M | 1.37M | 2.07M |
| EBITDA | 349.25K | 121.99K | -2.86M | -5.13M | -2.63M | -331.13K |
| Net Income | -495.83K | -607.73K | -3.58M | -5.11M | -4.93M | -63.14K |
Balance Sheet | ||||||
| Total Assets | 968.98K | 938.55K | 1.28M | 2.11M | 4.11M | 276.08K |
| Cash, Cash Equivalents and Short-Term Investments | 58.08K | 11.03K | 31.55K | 542.64K | 3.40M | 264.35K |
| Total Debt | 2.52M | 3.59M | 3.28M | 1.96M | 1.76M | 3.80M |
| Total Liabilities | 6.19M | 10.19M | 9.01M | 5.26M | 3.50M | 11.88K |
| Stockholders Equity | -5.22M | -9.25M | -7.73M | -3.15M | 602.59K | 264.21K |
Cash Flow | ||||||
| Free Cash Flow | -964.63K | 36.31K | -1.23M | -4.04M | -3.28M | -65.05K |
| Operating Cash Flow | -770.79K | 366.80K | -1.23M | -3.97M | -3.27M | -58.85K |
| Investing Cash Flow | -489.00K | -628.01K | 0.00 | -68.41K | 215.14K | -11.73K |
| Financing Cash Flow | 1.29M | 245.07K | 852.45K | 1.04M | 4.39M | 3.44M |
Comprehensive Healthcare Systems Inc Peers Comparison
UnderperformOutperform
Sector (51)
TSE:CHS
Comprehensive Healthcare Systems Inc
0.58
0.38
190.00%
TSE:CBP
Certive Solutions
0.01
0.00
0.00%
TSE:NEWU
Newtopia
0.01
0.00
0.00%
TSE:LITE
Spotlite360 Technologies
0.02
0.00
0.00%
TSE:NARA
PanGenomic Health, Inc. Class A
1.19
0.97
440.91%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.